Scholarlink

Background <p>Intra-articular corticosteroid injections represent a therapeutic option for the management of various pain conditions; however, they are not devoid of the potential for adverse drug reactions. In this study, we present a rare systemic adverse drug reaction that has not been previously described: thrombocytopenic purpura.</p> Case presentation <p>A 73-year-old&#xa0;white female patient suffering from severe acute knee osteoarthritis&#xa0;was administered an intra-articular corticosteroid injection (betamethasone) for the second time. Within a few hours, she developed generalized skin lesions characterized by purpuric lesions all over her skin. The mucosae were excluded from this phenomenon. A thrombocytopenia was associated. A skin biopsy revealed the presence of purpura, accompanied by leukocytoclastic vasculitis and immune deposits of the immunoglobulin A type.&#xa0;A thorough medical examination was conducted, including a comprehensive allergy assessment yielding negative results. However, a positive irritative intradermo-reaction for betamethasone was observed. The skin lesions regressed spontaneously within a period of 2 weeks.</p> Conclusion <p>The corticosteroid injection was likely to have caused the symptoms owing to the following evidence: firstly, the acute clinical presentation (only a few hours after the injection); secondly, the rapid improvement in the patient’s condition; and thirdly, the absence of further signs indicating other serious complications. Thrombocytopenic purpura, a rare systemic adverse drug reaction, has not been previously described.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Complication after knee intra-articular betamethasone injection, a thrombocytopenic purpura: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月31日

查看全文
  • Marine Fauny,
  • Audrey Fresse,
  • Damien Loeuille,
  • Isabelle Chary-Valckenaere

摘要

Background

Intra-articular corticosteroid injections represent a therapeutic option for the management of various pain conditions; however, they are not devoid of the potential for adverse drug reactions. In this study, we present a rare systemic adverse drug reaction that has not been previously described: thrombocytopenic purpura.

Case presentation

A 73-year-old white female patient suffering from severe acute knee osteoarthritis was administered an intra-articular corticosteroid injection (betamethasone) for the second time. Within a few hours, she developed generalized skin lesions characterized by purpuric lesions all over her skin. The mucosae were excluded from this phenomenon. A thrombocytopenia was associated. A skin biopsy revealed the presence of purpura, accompanied by leukocytoclastic vasculitis and immune deposits of the immunoglobulin A type. A thorough medical examination was conducted, including a comprehensive allergy assessment yielding negative results. However, a positive irritative intradermo-reaction for betamethasone was observed. The skin lesions regressed spontaneously within a period of 2 weeks.

Conclusion

The corticosteroid injection was likely to have caused the symptoms owing to the following evidence: firstly, the acute clinical presentation (only a few hours after the injection); secondly, the rapid improvement in the patient’s condition; and thirdly, the absence of further signs indicating other serious complications. Thrombocytopenic purpura, a rare systemic adverse drug reaction, has not been previously described.